[HTML][HTML] Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features

Y Cong, S Yang, X Rao - Journal of advanced research, 2020 - Elsevier
The infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is a global
threat to public health. Vancomycin remains one of the first-line drugs for the treatment of …

Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus

M Monaco, F Pimentel de Araujo, M Cruciani… - … therapy and prophylaxis, 2017 - Springer
Staphylococcus aureus is an important human pathogen, responsible for infections in the
community and the healthcare setting. Although much of the attention is focused on the …

[HTML][HTML] Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran

S Dibah, M Arzanlou, E Jannati… - Iranian journal of …, 2014 - ncbi.nlm.nih.gov
Materials and Methods In this cross-sectional study, a total of 41 isolates of S. aureus were
collected from clinical specimens at two teaching hospitals in Ardabil, Iran. All isolates were …

[HTML][HTML] VanA and vanB positive vancomycin-resistant Staphylococcus aureus among clinical isolates in Shiraz, South of Iran

S Saadat, K Solhjoo, MJ Norooz-Nejad… - Oman medical …, 2014 - ncbi.nlm.nih.gov
Objective The purpose of this study was to determine the prevalence of vancomycin-
resistant Staphylococcus aureus isolated from clinical samples in Shiraz hospitals. Methods …

The multifaceted resources and microevolution of the successful human and animal pathogen methicillin-resistant Staphylococcus aureus

AMS Figueiredo, FA Ferreira - Memórias do Instituto Oswaldo Cruz, 2014 - SciELO Brasil
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important bacterial
pathogens based on its incidence and the severity of its associated infections. In addition …

Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus infection in Europe

A Friães, C Resina, V Manuel, L Lito… - Epidemiology & …, 2015 - cambridge.org
We report on the follow-up and epidemiological study triggered by the isolation of the first
vancomycin-resistant Staphylococcus aureus (VRSA) detected in Europe. The patient and …

What's new in the treatment of serious MRSA infection?

NE Holmes, BP Howden - Current opinion in infectious diseases, 2014 - journals.lww.com
Several new MRSA-active agents are now approved for use, although much of the data is
derived from treatment of acute bacterial skin and skin structure infections or pneumonia …

[PDF][PDF] Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains

Z Moravvej, F Estaji, E Askari, K Solhjou… - Int J Antimicrob …, 2013 - researchgate.net
In his recent article published in International Journal of Antimicrobial Agents, Gould [1] e
xcellently reviewed the current evidence for the treatment of bacteraemia caused by …

[HTML][HTML] Prevalence of antibiotic resistance and virulence factors encoding genes in clinical Staphylococcus aureus isolates in Saudi Arabia

HH Abulreesh, SR Organji, GEH Osman… - … epidemiology and global …, 2017 - Elsevier
Background The present work intended to investigate the carriage of antibiotic resistance
and virulence genes in multidrug-resistant Staphylococcus aureus isolated from various …

Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of Staphylococcus aureus skin and soft …

CP Mocca, RA Brady, DL Burns - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Due to the emergence of highly virulent community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) infections, S. aureus has become a major threat to …